Enoxaparin sodium biosimilar (Gland Pharma)

依诺肝素钠生物类似药 (Gland Pharma)

Report date: 2022/01/20 09:29:34

Base Information

Drug NameEnoxaparin sodium biosimilar (Gland Pharma)
Drug Alias Name依诺肝素钠生物仿制药 (Gland Pharma)Cutenox
ClassificationBiologics > Biosimilar
Mechanisms of ActionThrombin inactivationFactor Xa inactivationAntithrombin-III activators
TargetsProthrombinCoagulation factor XAntithrombin-III
Therapy Area/IndicationsVenous ThrombosisVenous ThromboembolismMyocardial Infarction +[4] 
Global Approved IndicationsVenous ThrombosisVenous ThromboembolismMyocardial Infarction +[4] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved Date2014/10/01
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesGland Pharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGland Pharma
Inactive CompaniesN/A
Active IndicationsVenous ThrombosisVenous ThromboembolismMyocardial Infarction +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeB01AB05
Related LinksN/A